| 1 |
Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern[J]. Lancet, 2020, 395(10223): 470-473.
|
| 2 |
Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China -key questions for impact assessment[J]. N Engl J Med, 2020, 382(8): 692-694.
|
| 3 |
Huang CL, Wang YM, Li XW, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506.
|
| 4 |
Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223): 507-513.
|
| 5 |
Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J]. Science, 2020, 367(6483): 1260-1263.
|
| 6 |
Tan M, Liu Y, Zhou R, et al. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China[J]. Immunology, 2020, 160(3): 261-268.
|
| 7 |
Pellegrini D, Kawakami R, Guagliumi G, et al. Microthrombi as a major cause of cardiac injury in COVID-19: A pathologic study[J]. Circulation, 2021, 143(10): 1031-1042.
|
| 8 |
Sabatino J, Rosa SD, Salvo GD, et al. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis[J]. PLoS ONE, 2020, 15(8): e0237131.
|
| 9 |
Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)[J]. JAMA Cardiology, 2020, 5(7): 811-818.
|
| 10 |
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11): 1061-1069.
|
| 11 |
Liu PP, Blet A, Smyth D, et al. The science underlying COVID-19: implications for the cardiovascular system[J]. Circulation, 2020, 142(1): 68-78.
|
| 12 |
Pollack A, Kontorovich AR, Fuster V, et al. Viral myocarditis—diagnosis, treatment options and current controversies[J]. Nat Rev Cardiol, 2015, 12(11): 670-680.
|
| 13 |
Rao S, Sasser W, Diaz F, et al. Coronavirus associated fulminant myocarditis successfully treated with intravenous immunoglobulin and extracorporeal membrane oxygenation[J]. Chest, 2014, 146(4): 336A.
|
| 14 |
Moady G, Atar S. Quarantine-induced stress cardiomyopathy (Takotsubo syndrome) during the COVID-19 pandemic[J]. Isr Med Assoc J, 2021, 23(3): 149-152.
|
| 15 |
Babapoor-Farrokhran S, Gill D, Walker J, et al. Myocardial injury and COVID-19: possible mechanisms[J]. Life Sci, 2020, 253: 117723.
|
| 16 |
Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up[J]. Cardiovasc Res, 2022, 118(7): 1618-1666.
|
| 17 |
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395(10229): 1054-1062.
|
| 18 |
Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19[J]. Thromb Res, 2020, 191: 145-147.
|
| 19 |
Ren B, Yan F, Deng Z, et al. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan[J]. Circulation, 2020, 142(2): 181-183.
|
| 20 |
尹立雪, 李春梅, 谢明星, 等. 新型冠状病毒肺炎床旁超声心动图检查及远程诊断实施建议(第一版)[J/OL]. 中华医学超声杂志(电子版), 2020, 17(3): 226-243.
|
| 21 |
Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19[J]. Eur Heart J Cardiovasc Imaging, 2020, 21(9): 949-958.
|
| 22 |
Szekely Y, Lichter Y, Taieb P, et al. The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19) - a systematic echocardiographic study[J]. Circulation, 2020, 142(4): 342-353.
|
| 23 |
Kumar N, Oommen R, Thomson VS, et al. Assessment of left ventricular systolic function by velocity vector imaging[J]. Indian Heart J, 2012, 64(2): 146-149.
|
| 24 |
Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury[J]. Sci China Life Sci, 2020, 63(3): 364-374.
|
| 25 |
中华医学会超声医学分会超声心动图学组, 中国医师协会心血管分会超声心动图专业委员会. 超声心动图评估心脏收缩和舒张功能临床应用指南[J]. 中华超声影像学杂志, 2020, 29(6): 461-477.
|
| 26 |
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(12): 1321-1360.
|
| 27 |
Vitarelli A, Terzano C. Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography[J]. Heart Fail Rev, 2010, 15(1): 39-61.
|
| 28 |
Tello K, Gall H, Richter M, et al. Right ventricular function in pulmonary (arterial) hypertension[J]. Herz, 2019, 44(6): 509-516.
|
| 29 |
Günay N, Demiröz Ö, Kahyaoğlu M, et al. The effect of moderate and severe COVID-19 pneumonia on short-term right ventricular functions: a prospective observational single pandemic center analysis[J]. Int J Cardiovasc Imaging, 2021, 37(6): 1883-1890.
|
| 30 |
Li Y, Li H, Zhu S, et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19[J]. JACC Cardiovasc Imaging, 2020, 13(11): 2287-2299.
|
| 31 |
Bursi F, Santangelo G, Sansalone D, et al. Prognostic utility of quantitative offline 2D‐echocardiography in hospitalized patients with COVID-19 disease[J]. Echocardiography, 2020, 37(12): 2029-2039.
|
| 32 |
邢长洋, 李俏颖, 连建奇, 等. 重视超声系统监测在新型冠状病毒肺炎综合评估中的应用[J/CD]. 中华医学超声杂志(电子版), 2020, 17(3): 193-195.
|
| 33 |
Barbier C, Loubieres Y, Schmit C, et al. Respiratory changes in inferior vena cava diameter are helpful in predicting fluid responsiveness in ventilated septic patients [J]. Intensive Care Med, 2004, 30(9): 1740-1746.
|
| 34 |
Moulson N, Petek BJ, Drezner JA, et al. SARS-CoV-2 cardiac involvement in young competitive athletes[J]. Circulation, 2021, 144(4): 256-266.
|
| 35 |
Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging[J]. JACC Cardiovasc Imaging, 2020, 13(11): 2330-2339.
|
| 36 |
Knockaert DC. Cardiac involvement in systemic inflammatory diseases[J]. Eur Heart J, 2007, 28(15): 1797-1804.
|
| 37 |
Luetkens JA, Doerner J, Thomas DK, et al. Acute myocarditis: multiparametric cardiac MR imaging[J]. Radiology, 2014, 273(2): 383-392.
|
| 38 |
Chaikriangkrai K, Abbasi MA, Sarnari R, et al. Prognostic value of myocardial extracellular volume fraction and T2-mapping in heart transplant patients[J]. JACC Cardiovasc Imaging, 2020, 13(7): 1521-1530.
|
| 39 |
Li H, Zhu H, Yang ZX, et al. Tissue characterization by mapping and strain cardiac MRI to evaluate myocardial inflammation in fulminant myocarditis[J]. J Magn Reson Imaging, 2020, 52(3): 930-938.
|
| 40 |
Wang H, Li R, Zhou Z, et al. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance[J]. J Cardiovasc Magn Reson, 2021, 23(1): 14.
|
| 41 |
Karlstad Ø, Hovi P, Husby A, et al. SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents[J]. JAMA Cardiol, 2022, 7(6): 600-612.
|
| 42 |
Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis in seven adolescents following Pfizer-BioNTech COVID-19 vaccination[J]. Pediatrics, 2021: e2021052478.
|
| 43 |
Albert E, Aurigemma G, Saucedo J, et al. Myocarditis following COVID-19 vaccination[J]. Radiol Case Rep, 2021, 16(8): 2142-2145.
|